Abstract
Introduction Current estimates of pandemic spread using infectious disease models in Germany for SARS-CoV-2 often do not use age-specific infection parameters and are not always based on known contact matrices of the population. They also do not usually include setting-based information of reported cases and do not account for age-specific underdetection of reported cases. Here, we report likely pandemic spread using an age-structured model to understand the age- and setting-specific contribution of contacts to transmission during all phases of the COVID-19 pandemic in Germany.
Methods We developed a deterministic SEIRS model using a pre-pandemic contact matrix. The model is optimized to fit reported age-specific SARS-CoV-2 incidences from the Robert Koch Institute, includes information on setting-specific reported cases in schools and integrates age and pandemic period-specific parameters for underdetection of reported cases deduced from a large population-based seroprevalence study.
Results We showed that taking underreporting into account, younger adults and teenagers are the main contributors to infections during the first three pandemic waves in Germany. Overall, the contribution of contacts in schools to the total cases in the population was below 10% during the third wave.
Discussion Accounting for the pandemic phase and age-specific underreporting seems important to correctly identify those parts of the population where quarantine, testing, vaccination, and contact-reduction measures are likely to be most effective and efficient. In the future, we will aim to compare current model estimates with currently emerging during-pandemic age-specific contact survey data.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the European Unions Horizon 2020 research and innovation program under grant agreement No 101003480 (Project CORESMA) and the Initiative and Networking Fund of the Helmholtz Association. This research was part of a project funded by the Standing Conference of the Ministers of Education and Cultural Affairs (KMK) for the project COVID-SCHULEN. The research was also part of project COVIM: NaFOUniMedCovid19 (FKZ: 01KX2021) supported by the German Federal Ministry of Education and Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
